BREAKING Manuscript: Banoun, Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention

Sep 20th 2024 5:31am EDT

By Peter A. McCullough, MD, MPH Beginning in October, 2023, Beyfortus® (Nirsevimab) has been given routinely to all healthy newborns for the prevention of respiratory syncytial virus infection. High-tech synthetic antibodies have never been injected in a human on the first day of life before, so as one could expect, it is a brave new […]

Discuss on Nostr!

Nostr Note ID note1l5j49wlqtxcqdav3txw7urv6sp27r7439fpuav3qahcgstz7xktspcrpev Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social

New to Nostr?
Create an account now & join the conversation!

Promote it on DissentWatch!

  • To advertise this post for $0.02 per visit send bitcoins to the address below
  • The post will be promoted daily via social media & our "Featured News" display in multiple places
  • You can add more anytime
  • Ranking order in the Featured News box is based on the balance remaining


Received: 0 mBTC (0.00 USD)

Spent: 0 mBTC (0.00 USD)

Balance: 0 mBTC (0.00 USD)

The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.

REFRESH AMOUNTS